K Number
K113168
Device Name
DAILIES TOTAL DALIES TOTAL FOR ASTIGMATISM DAILIES TOTAL MULTIFOCAL DAILIES TOTAL MULTIFOCAL TORIC
Date Cleared
2012-03-30

(155 days)

Product Code
Regulation Number
886.5925
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
DAILIES TOTAL 1® (delefilcon A) spherical soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism. DAILIES TOTAL 1® (delefilcon A) toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism. DAILIES TOTAL 1 (delefilcon A) multifocal soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism. DAILIES TOTAL 1® (delefilcon A) multifocal toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less. The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.
Device Description
The lens material is 33% water and 67% delefilcon A, a silicone containing hydrogel with added phosphatidylcholine. The core lens material containing 33% water transitions through a water gradient to a hydrogel surface layer that exceeds 80% water. Lenses contain the color additive copper phthalocyanine, a light blue handling tint, which makes them easier to see when handling. Delefilcon A lens designs include spherical, toric, multifocal and toric multifocal lenses in the following parameter ranges: Diameter Range: 13.0 to 15.0 mm Base Curve Range: 8.0 to 9.2 mm Power Range: -20.00D to +20.00D Center Thickness: varies with design and power (0.09 mm for -3.00D spherical) Lenses have the following properties: Refractive index: 1.42 (hydrated) Light transmittance: ≥ 93% (@610 nm, -1.00D) Water content: 33% by weight in normal saline Surface water content: ≥ 80% Oxygen permeability: 140 x 10-11 [(cm2 /sec)(ml O2 /ml.mmHg)] measured at 35°C (intrinsic Dk-Coulometric method) Each lens is packaged in a foil-sealed plastic containing phosphate buffered saline solution with approximately 0.3% of polymeric wetting agents consisting of copolymers of polyamidoamine and poly(acrylamide-acrylic acid) and are steam sterilized.
More Information

Not Found

No
The document describes a physical contact lens and its material properties, design parameters, and clinical study results. There is no mention of software, algorithms, or data processing that would indicate the use of AI or ML.

No
The device is indicated for the "optical correction of refractive ametropia" which is a corrective function, not a therapeutic treatment for disease.

No

Explanation: The device is a soft contact lens for optical correction of refractive ametropia (myopia, hyperopia, astigmatism, and presbyopia). It is not designed to diagnose any disease or condition.

No

The device described is a physical contact lens made of a specific material and design, intended for optical correction. It is not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Function: The DAILIES TOTAL 1® contact lenses are used for the optical correction of refractive errors (myopia, hyperopia, astigmatism, presbyopia) by being placed directly on the eye. They do not analyze any bodily specimens.
  • Intended Use: The intended use clearly states the purpose is optical correction of vision problems.
  • Device Description: The description focuses on the physical properties and materials of the contact lens itself.
  • Performance Studies: The studies evaluate the safety and efficacy of the lenses in terms of fit, vision, comfort, health, and handling when worn on the eye. They do not involve the analysis of biological samples.

Therefore, the DAILIES TOTAL 1® contact lenses fall under the category of medical devices, but not specifically In Vitro Diagnostic devices.

N/A

Intended Use / Indications for Use

DAILIES TOTAL1® (delefilcon A) spherical soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism.

DAILIES TOTAL 1® (delefilcon A) toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism.

DAILIES TOTAL 1 (delefilcon A) multifocal soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism.

DAILIES TOTAL 1® (delefilcon A) multifocal toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less.

The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

Product codes

LPL, MVN

Device Description

The lens material is 33% water and 67% delefilcon A, a silicone containing hydrogel with added phosphatidylcholine. The core lens material containing 33% water transitions through a water gradient to a hydrogel surface layer that exceeds 80% water. Lenses contain the color additive copper phthalocyanine, a light blue handling tint, which makes them easier to see when handling.

Delefilcon A lens designs include spherical, toric, multifocal and toric multifocal lenses in the following parameter ranges:

  • Diameter Range: 13.0 to 15.0 mm.
  • Base Curve Range: 8.0 to 9.2 mm.
  • Power Range: -20.00D to +20.00D.
  • Center Thickness: varies with design and power (0.09 mm for -3.00D spherical).

Lenses have the following properties:

  • Refractive index: 1.42 (hydrated).
  • Light transmittance: ≥ 93% (@610 nm, -1.00D).
  • Water content: 33% by weight in normal saline.
  • Surface water content: ≥ 80%.
  • Oxygen permeability: 140 x 10-11 [(cm2 /sec)(ml O2 /ml.mmHg)] measured at 35°C (intrinsic Dk-Coulometric method).

Each lens is packaged in a foil-sealed plastic containing phosphate buffered saline solution with approximately 0.3% of polymeric wetting agents consisting of copolymers of polyamidoamine and poly(acrylamide-acrylic acid) and are steam sterilized. The compatibility and package integrity of the blister pack packaging system has been demonstrated and successfully used for other marketed contact lens products, and packaged lenses are effectively steam sterilized in a validated autoclave. Blister pack containers are labeled with the lens parameters, lot number and product expiration date. The expiration date has been established through stability studies that have assessed the chemical and physical stability of the lens and integrity of the package (ability to maintain sterility). Shelf-life studies are ongoing to establish and extend the labeled expiration date.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

eyes / cornea

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Clinical Testing:
A three-month clinical study was conducted to assess the safety and efficacy of DAILIES TOTAL1® (delefilcon A) soft contact lenses for single use, daily disposable wear. The clinical study also provided data to establish substantial equivalence with the predicate, control lens.

The study evaluated 60 delefilcon A (test) subjects in a 2:1 ratio with the 30 narafilcon B (control) subjects in a prospective, randomized, parallel group design. The primary safety and efficacy variables were biomicroscopy findings and visual acuity respectively. Additional variables tested include refraction, keratometry, and subjective ratings of vision, comfort and handling.

The study results showed similar performance between the test delefilcon A and control narafilcon B lenses in the clinically relevant areas of fit, vision, comfort, health and handling when worn on a daily disposable wear basis.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K100349

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 886.5925 Soft (hydrophilic) contact lens.

(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.

0

MAR3
02012

Image /page/0/Picture/1 description: The image shows a sequence of handwritten digits and a letter. The sequence starts with the letter 'K', followed by the numbers '113168'. The numbers are written in a simple, slightly irregular style, typical of handwriting.

CIDA VISION.
Shared Passion for Healthy Vision and Better Life

CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097

27-Mar-2012, v03 Page 1 of 4

Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence

510(k) Summary - K113168

1. Submitter Information:

| Company: | CIBA VISION Corporation
11460 Johns Creek Parkway
Duluth, Georgia USA 30097 |
|------------------------------------|-----------------------------------------------------------------------------------|
| Contact Person: | Alicia M. Plesnarski, RAC
Director, Regulatory Affairs |
| Telephone:
Facsimile:
Email: | 678-415-3924
678-415-3454
alicia.plesnarski@cibavision.com |

2. Device Name:

Date Prepared:

  • Soft Contact Lens ● Common Name:
  • DAILIES TOTAL 1® (delefilcon A) Trade/Proprietary Name: .

27-Mar-2012

  • Daily Wear Soft Contact Lens � Classification Name:
  • Class II [21 CFR 886.5925 (b) (1)] Device Classification: .

3. Predicate Device:

· The predicate device is Johnson & Johnson VISTAKON® 1-DAY ACUVUE® TruEye (narafilcon B) soft contact lenses packaged in buffered saline. Narafilcon B lenses belona to ISO Group V (silicone hydrogel). Johnson & Johnson VISTAKON 1-DAY ACUVUE TruEye lenses have FDA 510(k) clearance per K100349, 21-May-2010.

4. Description of Device:

The lens material is 33% water and 67% delefilcon A, a silicone containing hydrogel with added phosphatidylcholine. The core lens material containing 33% water transitions through a water gradient to a hydrogel surface layer that exceeds 80% water. Lenses contain the color additive copper phthalocyanine, a light blue handling tint, which makes them easier to see when handling

Delefilcon A lens designs include spherical, toric, multifocal and toric multifocal lenses in the following parameter ranges:

  • 13.0 to 15.0 mm . Diameter Range:
  • Base Curve Range: 8.0 to 9.2 mm .
  • -20.00D to +20.00D � Power Range:
  • Center Thickness: varies with design and power � (0.09 mm for -3.00D spherical)

1

CIBAVISION.

Shared Passion for Healthy Vision and Better Life

.

CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097

27-Mar-2012. v03 Page 2 of 4

Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence

Lenses have the following properties:

  • 1.42 (hydrated) Refractive index: .
    • ≥ 93% (@610 nm, -1.00D) Light transmittance:
  • 33% by weight in normal saline Water content: .
  • Surface water content: ≥ 80% .
  • 140 x 10-11 Oxygen permeability . [{cm2 /sec)(ml O2 /ml.mmHg}] measured at 35°C (intrinsic Dk-Coulometric method)

Each lens is packaged in a foil-sealed plastic containing phosphate buffered saline solution with approximately 0.3% of polymeric wetting agents consisting of copolymers of polyamidoamine and poly(acrylamide-acrylic acid) and are steam sterilized. The compatibility and package integrity of the blister pack packaging system has been demonstrated and successfully used for other marketed contact lens products, and packaged lenses are effectively steam sterilized in a validated autoclave. Blister pack containers are labeled with the lens parameters, lot number and product expiration date. The expiration date has been established through stability studies that have assessed the chemical and physical stability of the lens and integrity of the package (ability to maintain sterility). Shelf-life studies are ongoing to establish and extend the labeled expiration date.

5. Indications for Use:

DAILIES TOTAL1® (delefilcon A) spherical soft contact ienses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with up to approximately 1.50 diopters of astigmatism.

DAILIES TOTAL 10 for Astigmatism (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism.

DAILIES TOTAL 1 Multifocal (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism.

DAILIES TOTAL 1 Multifocal Toric (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less.

The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

2

CIBA VISION TM
Shared Passion for Healthy Vision and Better Life

CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097

27-Mar-2012, v03 Page 3 of 4

Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence

6. Description of Safety and Substantial Equivalence:

A series of non-clinical tests were performed to characterize lens material properties and establish substantial equivalence to the predicate device. All testing was conducted in accordance with the May 1994 FDA guidance document titled Premarket Notification 510(k) Guidance Document for Daily Wear Contact Lenses and in conformance to applicable device regulations. Results verify that delefilcon A contact lenses are nontoxic and biocompatible, have material characteristics in common with currently marketed soft contact lenses intended for vision correction and demonstrate substantial equivalence to the previously FDA cleared predicate (control) lenses listed in Table 1.

Predicate DeviceNew Device
Product NameJohnson & Johnson®
VISTAKON® 1-DAY
ACUVUE® TruEye™
(narafilcon B)CIBA VISION®
DAILIES TOTAL1®
(delefilcon A)
Intended UseDaily Disposable WearDaily Disposable Wear
Mode of ActionWhen hydrated and placed on
the cornea, lenses act as a
refracting medium to focus
light rays on the retina.When hydrated and placed on
the cornea, lenses act as a
refracting medium to focus
light rays on the retina.
510(k) NumberK100349To be assigned
Lens Material Group **ISO Group VISO Group V
Manufacturing MethodMoldedLightStream
Sterilization MethodMoist HeatMoist Heat
PackagingBlister PackBlister Pack
Handling TintLt. BlueLt. Blue
Refractive Index1.411.42
Water Content (%)4833
Oxygen permeability55140
BC/Diameter (mm)8.5/14.28.5/14.1
Power (D)variousvarious

Table 1. Substantial Equivalence Comparison

**Per EN ISO 18369-1/Amd.1:2009

3

K113168

CIBAVISION.

Shared Passion for Healthy Vision and Better Life

CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097

27-Mar-2012, v03 Page 4 of 4

Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence

Conclusions drawn from Studies

Nonclinical Testing:

A series of nonclinical testing was performed to verify substantial equivalence of delefiloon A contact lenses to the predicate device. Non-clinical biocompatibility testing was conducted in accordance with the GLP regulation (21 CFR Part 58). The results of all non-clinical testing demonstrate:

  • The lens material and extracts of the device are non toxic and non-irritating. .
  • The device has optical, dimensional and physico-chemical properties in common . with currently marketed soft contact lenses intended for vision correction and consistent with or better than, the predicate lenses tested.
  • The lenses are compatible with commonly available contact iens rewetting drops and . saline solutions.

Clinical Testing:

A three-month clinical study was conducted to assess the safety and efficacy of DAILIES TOTAL1® (delefilcon A) soft contact lenses for single use, daily disposable wear. The clinical study also provided data to establish substantial equivalence with the predicate, control lens.

The study evaluated 60 delefilcon A (test) subjects in a 2:1 ratio with the 30 narafilcon B (control) subjects in a prospective, randomized, parallel group design. The primary safety and efficacy variables were biomicroscopy findings and visual acuity respectively. Additional variables tested include refraction, keratometry, and subjective ratings of vision, comfort and handling.

The study results showed similar performance between the test delefilcon A and control narafilcon B lenses in the clinically relevant areas of fit, vision, comfort, health and handling when worn on a daily disposable wear basis.

Risks and Benefits:

The risks of the subject device are the same as those normally attributed to the wearing of silicone hydrogel contact lenses on a single use, daily wear basis. The benefits to the patient are the same as those for other silicone hydrogel contact lenses.

Substantial Equivalence:

Delefilcon A soft contact lenses are substantially equivalent to the predicate contact lens and similar to other daily wear soft contact lenses in terms of material water content (33% water), ionic characteristics, ISO Group V: silicone hydrogel and indications for use.

Any differences which may exist between the delefilcon A soft contact lens and other ISO Group V silicone hydrogel soft contact lenses do not adversely affect the safety and effectiveness of the device when worn under single use, daily wear conditions.

4

Image /page/4/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized caduceus-like symbol with three lines extending upwards, representing health and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the symbol.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -- WO66-G609 Silver Spring, MD 20993-0002

Ciba Vision Corporation c/o Ms. Alicia M. Plesnarski, RAC Director, Regulatory Affairs 11460 Johns Creek Parkway Duluth, GA 30097

MAR 3 0 2012

Re: K113168

Trade/Device Name: DAILIES TOTAL1® (delefilcon A) Soft Contact Lenses

for Daily Disposable Wear Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) Contact Lens Regulatory Class: Class II Product Codes: LPL, MVN Dated: March 21, 2012 Received: March 22, 2012

Dear Ms. Plesnarski:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in-the Code of Federal-Regulations, Title 21, Parts 800 to 898 -- In-addition-FDA-maypublish further announcements concerning your device in the Federal Register.

5

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Kesia Alexander

Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

6

510(k) Number (if known):

K113168

Device Name:

DAILIES TOTAL 1® (delefilcon A) Soft Contact Lenses

Indications For Use:

DAILIES TOTAL 1® (delefilcon A) spherical soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism.

DAILIES TOTAL 1® (delefilcon A) toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism.

DAILIES TOTAL 1 (delefilcon A) multifocal soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism.

DAILIES TOTAL 1® (delefilcon A) multifocal toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less.

The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.

X Prescription Use: AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH. Office of Device Evaluation (ODE)

Marc Robboy


(Division Sign-Off)

Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices

510(k) Number K113168